Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial

被引：0

作者：

Wester, Ruth ^{[1
]}

Zweegman, Sonja ^{[2
]}

van der Holt, Bronno ^{[3
]}

Kersten, Marie Jose ^{[2
]}

Vellenga, Edo ^{[4
]}

van Marwijk-Kooy, Marinus ^{[5
]}

Asselbergs, Emelie ^{[1
]}

de Weerdt, Okke ^{[6
]}

Minnema, Monique C. ^{[7
]}

Lonergan, Sarah ^{[1
]}

Palumbo, Antonio ^{[8
]}

Broijl, Annemiek ^{[1
]}

Sonneveld, Pieter ^{[1
]}

机构：

[1] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands

[2] Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands

[3] Erasmus MC Canc Inst, Dept Hematol, HOVON Data Ctr, Rotterdam, Netherlands

[4] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands

[5] Isala Clin, Dept Hematol, Zwolle, Netherlands

[6] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands

[7] Univ Utrecht, Dept Hematol, UMC Utrecht, Utrecht, Netherlands

[8] Univ Turin, Azienda Osped Univ Citta Salute & Sci Torino, Div Hematol, Myeloma Unit, Turin, Italy

来源：

HEMASPHERE | 2020年 / 4卷 / 04期

关键词：

D O I：

10.1097/HS9.0000000000000370

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：3

共 6 条

[1] Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study [J].

Dimopoulos, Meletios A. ;

Moreau, Philippe ;

Palumbo, Antonio ;

Joshua, Douglas ;

Pour, Ludek ;

Hajek, Roman ;

Facon, Thierry ;

Ludwig, Heinz ;

Oriol, Albert ;

Goldschmidt, Hartmut ;

Rosinol, Laura ;

Straub, Jan ;

Suvorov, Aleksandr ;

Araujo, Carla ;

Rimashevskaya, Elena ;

Pika, Tomas ;

Gaidano, Gianluca ;

Weisel, Katja ;

Goranova-Marinova, Vesselina ;

Schwarer, Anthony ;

Minuk, Leonard ;

Masszi, Tamas ;

Karamanesht, Ievgenii ;

Offidani, Massimo ;

Hungria, Vania ;

Spencer, Andrew ;

Orlowski, Robert Z. ;

Gillenwater, Heidi H. ;

Mohamed, Nehal ;

Feng, Shibao ;

Chng, Wee-Joo .

LANCET ONCOLOGY, 2016, 17 (01) :27-38

[2] Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma [J].

Harousseau, Jean-Luc ;

Dimopoulos, Meletios A. ;

Wang, Michael ;

Corso, Alessandro ;

Chen, Christine ;

Attal, Michel ;

Spencer, Andrew ;

Yu, Zhinuan ;

Olesnyckyj, Marta ;

Zeldis, Jerome B. ;

Knight, Robert D. ;

Weber, Donna M. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (10) :1738-1744

[3] Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival [J].

Jose Lahuerta, Juan ;

Victoria Mateos, Maria ;

Martinez-Lopez, Joaquin ;

Rosinol, Laura ;

Sureda, Anna ;

de la Rubia, Javier ;

Garcia-Larana, Jose ;

Martinez-Martinez, Rafael ;

Hernandez-Garcia, Miguel T. ;

Carrera, Dolores ;

Besalduch, Joan ;

de Arriba, Felipe ;

Maria Ribera, Jose ;

Escoda, Lourdes ;

Hernandez-Ruiz, Belen ;

Garcia-Frade, Javier ;

Rivas-Gonzalez, Concepcion ;

Alegre, Adrian ;

Blade, Joan ;

San Miguel, Jesus F. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (35) :5775-5782

[4] Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial [J].

Mateos, Maria-Victoria ;

Oriol, Albert ;

Martinez-Lopez, Joaquin ;

Gutierrez, Norma ;

Teruel, Ana-Isabel ;

Lopez de la Guia, Ana ;

Lopez, Javier ;

Bengoechea, Enrique ;

Perez, Montserrat ;

Polo, Marta ;

Palomera, Luis ;

de Arriba, Felipe ;

Gonzalez, Yolanda ;

Hernandez, Jose-Mariano ;

Granell, Miquel ;

Bello, Jose-Luis ;

Bargay, Joan ;

Penalver, Francisco-Javier ;

Ribera, Jose-Maria ;

Martin-Mateos, Maria-Luisa ;

Garcia-Sanz, Ramon ;

Lahuerta, Juan-Jose ;

Blade, Joan ;

San-Miguel, Jesus F. .

BLOOD, 2012, 120 (13) :2581-2588

[5] Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study [J].

Moreau, Philippe ;

Attal, Michel ;

Hulin, Cyrille ;

Arnulf, Bertrand ;

Belhadj, Karim ;

Benboubker, Lotfi ;

Bene, Marie C. ;

Broijl, Annemiek ;

Caillon, Helene ;

Caillot, Denis ;

Corre, Jill ;

Delforge, Michel ;

Dejoie, Thomas ;

Doyen, Chantal ;

Facon, Thierry ;

Sonntag, Cecile ;

Fontan, Jean ;

Garderet, Laurent ;

Jie, Kon-Siong ;

Karlin, Lionel ;

Kuhnowski, Frederique ;

Lambert, Jerome ;

Leleu, Xavier ;

Lenain, Pascal ;

Macro, Margaret ;

Mathiot, Claire ;

Orsini-Piocelle, Frederique ;

Perrot, Aurore ;

Stoppa, Anne-Marie ;

van de Donk, Niels W. C. J. ;

Wuilleme, Soraya ;

Zweegman, Sonja ;

Kolb, Brigitte ;

Touzeau, Cyrille ;

Roussel, Murielle ;

Tiab, Mourad ;

Marolleau, Jean-Pierre ;

Meuleman, Nathalie ;

Vekemans, Marie-Christiane ;

Westerman, Matthijs ;

Klein, Saskia K. ;

Levin, Mark-David ;

Fermand, Jean Paul ;

Escoffre-Barbe, Martine ;

Eveillard, Jean-Richard ;

Garidi, Reda ;

Ahmadi, Tahamtan ;

Zhuang, Sen ;

Chiu, Christopher ;

Pei, Lixia .

LANCET, 2019, 394 (10192) :29-38

[6] Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial [J].

Wester, Ruth ;

van der Holt, Bronno ;

Asselbergs, Emelie ;

Zweegman, Sonja ;

Kersten, Marie Jose ;

Vellenga, Edo ;

Kooy, Marinus van Marwijk ;

de Weerdt, Okke ;

Minnema, Monique ;

Lonergan, Sarah ;

Palumbo, Antonio ;

Lokhorst, Henk ;

Broijl, Annemiek ;

Sonneveld, Pieter .

HAEMATOLOGICA, 2019, 104 (11) :2265-2273

← 1 →